NASDAQ : AURA
Aura Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.295 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 652.82M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 35.29M | 22.49M | 22.81M | 19.76M | 18.06M | 10.09M |
| Research & Development | 102.78M | 90.30M | 73.30M | 65.23M | 42.24M | 25.16M |
| Operating Expenses | 138.08M | 112.79M | 96.12M | 84.99M | 60.30M | 35.25M |
| Operating Income | -138.08M | -112.79M | -96.12M | -84.99M | -60.30M | -35.25M |
| Interest & Investment Income | 6.86M | 6.63M | 9.43M | 8.59M | 1.86M | 13.00K |
| Other Non Operating Income (Expenses) | 291.00K | 77.00K | -120.00K | -76.00K | -14.00K | -11.00K |
| EBT Excluding Unusual Items | -130.93M | -106.08M | -86.81M | -76.48M | -58.45M | -35.25M |
| Gain (Loss) on Sale of Assets | 208.00K | -318.00K | -3.00K | |||
| Pretax Income | -130.93M | -106.08M | -86.81M | -76.27M | -58.76M | -35.25M |
| Income Tax Expense | 81.00K | 108.00K | 112.00K | 137.00K | ||
| Net Income | -131.01M | -106.19M | -86.92M | -76.41M | -58.76M | -35.25M |
| Preferred Dividends & Other Adjustments | 10.94M | |||||
| Net Income to Common | -131.01M | -106.19M | -86.92M | -76.41M | -58.76M | -46.19M |
| Shares Outstanding (Basic) | 73.91M | 60.34M | 49.65M | 39.62M | 29.94M | 5.16M |
| Shares Outstanding (Diluted) | 73.91M | 60.34M | 49.65M | 39.62M | 29.94M | 5.16M |
| EPS (Basic) | -1.77 | -1.76 | -1.75 | -1.93 | -1.96 | -8.95 |
| EPS (Diluted) | -1.77 | -1.76 | -1.75 | -1.93 | -1.96 | -8.95 |
| Free Cash Flow | -103.35M | -85.19M | -81.06M | -64.56M | -55.70M | -34.53M |
| Free Cash Flow Per Share | -1.40 | -1.41 | -1.63 | -1.63 | -1.86 | -6.69 |
| EBITDA | -136.99M | -111.66M | -94.89M | -83.70M | -59.12M | -34.42M |
| D&A For EBITDA | 1.09M | 1.13M | 1.22M | 1.29M | 1.18M | 831.00K |
| EBIT | -138.08M | -112.79M | -96.12M | -84.99M | -60.30M | -35.25M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 67.84M | 59.52M | 31.69M | 41.06M | 121.58M | 149.06M |
| Short-Term Investments | 256.00M | 84.73M | 119.40M | 185.09M | 67.23M | |
| Cash & Short-Term Investments | 323.84M | 144.24M | 151.09M | 226.15M | 188.81M | 149.06M |
| Prepaid Expenses | 651.00K | 1.67M | 1.70M | 1.82M | 2.17M | 2.73M |
| Restricted Cash | 19.00K | 20.00K | 23.00K | |||
| Other Current Assets | 2.77M | 3.83M | 7.83M | 3.81M | 5.70M | 1.88M |
| Total Current Assets | 329.03M | 149.74M | 160.62M | 231.79M | 196.70M | 153.70M |
| Property, Plant & Equipment | 17.19M | 18.45M | 20.59M | 22.00M | 26.04M | 6.20M |
| Other Long-Term Assets | 1.91M | 1.24M | 1.29M | 1.28M | 1.19M | 125.00K |
| Total Assets | 348.13M | 169.43M | 182.50M | 255.07M | 223.94M | 160.03M |
| Accounts Payable | 2.25M | 1.55M | 2.30M | 1.79M | 2.92M | 2.40M |
| Accrued Expenses | 13.11M | 13.35M | 9.27M | 6.95M | 4.25M | 3.83M |
| Current Portion of Leases | 3.29M | 3.24M | 3.15M | 2.69M | 2.96M | 615.00K |
| Other Current Liabilities | 908.00K | 242.00K | 188.00K | 935.00K | 325.00K | 506.00K |
| Total Current Liabilities | 19.56M | 18.38M | 14.91M | 12.36M | 10.46M | 7.36M |
| Long-Term Leases | 13.30M | 14.13M | 15.62M | 16.87M | 17.89M | 360.00K |
| Total Liabilities | 32.86M | 32.52M | 30.53M | 29.23M | 28.35M | 7.71M |
| Additional Paid-In Capital | 914.77M | 617.43M | 525.93M | 512.62M | 406.56M | 304.45M |
| Retained Earnings | -559.74M | -480.42M | -374.23M | -287.31M | -210.90M | -152.14M |
| Comprehensive Income & Other | -670.00K | -102.00K | 263.00K | 539.00K | -72.00K | |
| Total Common Equity | 315.27M | 136.91M | 151.97M | 225.85M | 195.58M | 152.31M |
| Shareholders' Equity | 315.27M | 136.91M | 151.97M | 225.85M | 195.58M | 152.31M |
| Total Liabilities & Equity | 348.13M | 169.43M | 182.50M | 255.07M | 223.94M | 160.03M |
| Total Debt | 16.59M | 17.38M | 18.77M | 19.56M | 20.86M | 975.00K |
| Net Cash (Debt) | 307.25M | 126.86M | 132.32M | 206.59M | 167.95M | 148.09M |
| Net Cash Per Share | 4.16 | 2.10 | 2.67 | 5.21 | 5.61 | 28.70 |
| Filing Date Shares Outstanding | 103.70M | 64.15M | 50.23M | 49.50M | 37.80M | 29.22M |
| Total Common Shares Outstanding | 103.48M | 63.59M | 50.00M | 49.35M | 37.77M | 29.21M |
| Working Capital | 309.47M | 131.36M | 145.71M | 219.44M | 186.25M | 146.35M |
| Book Value Per Share | 3.05 | 2.15 | 3.04 | 4.58 | 5.18 | 5.21 |
| Tangible Book Value | 315.27M | 136.91M | 151.97M | 225.85M | 195.58M | 152.31M |
| Tangible Book Value Per Share | 3.05 | 2.15 | 3.04 | 4.58 | 5.18 | 5.21 |
| Machinery | 9.01M | 8.98M | 8.46M | 7.79M | 7.43M | 5.64M |
| Construction In Progress | 294.00K | 228.00K | 272.00K | 391.00K | 1.80M | 2.37M |
| Leasehold Improvements | 471.00K | 471.00K | 471.00K | 13.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -131.01M | -106.19M | -86.92M | -76.41M | -58.76M | -35.25M |
| Depreciation & Amortization | 1.09M | 1.13M | 1.22M | 1.29M | 1.18M | 831.00K |
| Loss (Gain) From Sale of Assets | 208.00K | -22.00K | 3.00K | |||
| Loss (Gain) From Sale of Investments | -1.39M | -1.55M | -4.66M | -3.99M | -527.00K | |
| Stock-Based Compensation | 23.16M | 14.32M | 11.72M | 8.77M | 6.41M | 2.31M |
| Other Operating Activities | 1.65M | 1.58M | 1.47M | 1.84M | 968.00K | 15.00K |
| Change in Accounts Payable | 870.00K | -846.00K | 482.00K | -1.04M | 340.00K | 1.05M |
| Change in Other Net Operating Assets | 2.63M | 6.82M | -3.12M | 5.48M | -4.19M | -1.37M |
| Operating Cash Flow | -103.01M | -84.74M | -79.81M | -63.85M | -54.60M | -32.41M |
| Capital Expenditures | -344.00K | -447.00K | -1.25M | -709.00K | -1.09M | -2.12M |
| Investment in Securities | -184.99M | 36.04M | 70.07M | -113.25M | -66.78M | |
| Investing Cash Flow | -185.33M | 35.59M | 68.82M | -113.96M | -67.87M | -2.12M |
| Issuance of Common Stock | 266.89M | 53.74M | 1.59M | 97.29M | 95.63M | 79.05M |
| Other Financing Activities | 21.38M | 23.41M | -15.00K | |||
| Financing Cash Flow | 249.18M | 77.16M | 1.59M | 97.29M | 95.63M | 166.26M |
| Foreign Exchange Rate Adjustments | -374.00K | -186.00K | ||||
| Net Cash Flow | -39.53M | 27.82M | -9.39M | -80.52M | -26.84M | 131.72M |
| Free Cash Flow | -103.35M | -85.19M | -81.06M | -64.56M | -55.70M | -34.53M |
| Free Cash Flow Per Share | -1.40 | -1.41 | -1.63 | -1.63 | -1.86 | -6.69 |
| Levered Free Cash Flow | -56.32M | -48.09M | -50.17M | -39.34M | -33.69M | -20.52M |
| Unlevered Free Cash Flow | -56.32M | -48.09M | -50.17M | -39.34M | -33.69M | -20.52M |
| Cash Income Tax Paid | 100.00K | 100.00K | 100.00K | |||
| Change in Working Capital | 3.50M | 5.97M | -2.64M | 4.44M | -3.85M | -315.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 636.75M | 346.09M | 410.60M | 436.44M | 388.92M | 496.00M |
| Enterprise Value | 329.50M | 201.98M | 255.31M | 307.58M | 298.47M | 630.59M |
| Last Close Price | 6.14 | 5.45 | 8.22 | 8.86 | 10.50 | 16.98 |
| PB Ratio | 2.02 | 2.53 | 2.70 | 1.93 | 1.99 | 3.26 |
| P/TBV Ratio | 2.02 | 2.53 | 2.70 | 1.93 | 1.99 | 3.26 |
| Debt / Equity Ratio | 0.05 | 0.13 | 0.12 | 0.09 | 0.11 | 0.01 |
| Net Debt / Equity Ratio | -0.97 | -0.93 | -0.87 | -0.92 | -0.86 | -0.97 |
| Net Debt / EBITDA Ratio | 2.24 | 1.14 | 1.39 | 2.47 | 2.84 | 4.30 |
| Net Debt / FCF Ratio | 2.97 | 1.49 | 1.63 | 3.20 | 3.02 | 4.29 |
| Quick Ratio | 16.65 | 7.85 | 10.13 | 18.30 | 18.06 | 20.27 |
| Current Ratio | 16.82 | 8.15 | 10.77 | 18.76 | 18.81 | 20.90 |
| Return on Equity (ROE) | -53.49% | -73.52% | -46.01% | -36.26% | -33.78% | -41.07% |
| Return on Assets (ROA) | -31.24% | -40.06% | -27.46% | -22.18% | -19.63% | -24.19% |
| Return on Capital Employed (ROCE) | -42.00% | -74.70% | -57.40% | -35.00% | -28.20% | -23.10% |
| Earnings Yield | -28.87% | -30.68% | -21.17% | -17.51% | -15.11% | -7.11% |
| FCF Yield | -16.23% | -24.61% | -19.74% | -14.79% | -14.32% | -6.96% |
| Buyback Yield / Dilution | -42.27% | -21.52% | -25.32% | -32.34% | -480.18% | -1,305.21% |